Zimmer, Markie
Kadia, Tapan
Article History
Accepted: 4 August 2023
First Online: 9 September 2023
Declarations
:
: Markie Zimmer declares no conflict of interest. Tapan Kadia has received grants or contracts from AbbVie, Amgen, Ascentage, Astella, Astex, AstraZeneca, BMS, Celgene, Cellenkos, Cyclacel, Delta-Fly Pharma, Genfleet, Genentech, Glycomimetrics, Iterion, Janssen, Jazz, Pfizer, Pulmotect, Regeneron, Sellas; consulting fees from Abbvie, Agios, Daiichi Sankyo, Genentech, Genzyme, Jazz, Liberum, Novartis, Pfizer, PinotBio, Pulmotect, Sanofi-Aventis; and payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Genzyme.
: This article does not contain any studies with human or animal subjects performed by any of the authors.